Search Results 181-190 of 18205 for peptides
Receipt of glucagon-like peptide-1 agonists. Adults lacking the capacity to consent for self. Note: Other protocol defined Inclusion/Exclusion Criteria may ...
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is also used together with diet and exercise to help lose weight and keep the ...
... peptide receptor radionuclide therapy (PRRT). The latest treatments. People who seek care at Mayo Clinic have access to the latest treatments, including ...
The purpose of this study is to determine the effects of blocking the receptors of the Glucagon-like Peptide-1 (GLP-1) hormone after different types of ...
A personalized neoantigen peptide vaccine containing up to 20 unique peptides will be manufactured for each qualifying patient based on the results. Immune ...
Any prescriptions provided by your doctor, such as glucagon-like peptide 1 (GLP-1) medications like Wegovy or Zepbound, or other obesity medications such as ...
Radiation used in peptide receptor radionuclide therapy could be detected by sensitive radiation detectors at U.S. ports of entry, including international ...
The purpose of this study is to screen for unique or characteristic circulating peptides, hormonal biomarkers and circulating mRNA in patients who have ...
... peptides to treat cardiovascular disease. He has been continuously funded by the National Institutes of Health (NIH) since 1986. Along with his team, he has ...
... peptide (NT-proBNP) within 90 days of randomization: For patients in normal sinus rhythm: N-terminal-probrain natriuretic peptide (NT-proBNP) >600 pg/mL (or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.